Growth arrest and DNA-damage-inducible 45β (GADD45B); mitogen-activated protein kinase kinase 7 (MAP2K7; MKK7) BriefCommunication Pages: 1256 - 1256
Major histocompatibility complex class I A (HLA-A); HLA-B; HLA-C BriefCommunication Pages: 1261 - 1261
Platelet derived growth factor BB (PDGF-BB); cathepsin K (CTSK) BriefCommunication Pages: 1268 - 1268
Granulocyte macrophage colony-stimulating factor receptor (CSF2RA; GMR; CD116); granulocyte macrophage colony-stimulating factor 2 receptor-β (CSF2RB; CD131) BriefCommunication Pages: 1270 - 1270
Driver-gene inference by genetic-genomics and information theory (DIGGIT) algorithm to identify disease driver mutations BriefCommunication Pages: 1271 - 1271
Mutant neuroblastoma Ras viral (v-Ras) oncogene ( Nras ) mouse model of melanoma BriefCommunication Pages: 1273 - 1273
Adhesive polyvinyl alcohol (PVA)-chitosan films for sublingual drug delivery BriefCommunication Pages: 1274 - 1274
Drug-silica nanoconjugates for tumor-specific delivery of cytotoxic agents BriefCommunication Pages: 1275 - 1275
Inhalable micelles expressing a lung-targeting peptide for delivery of therapies to treat pulmonary arterial hypertension (PAH) BriefCommunication Pages: 1276 - 1276
Generation of endothelial colony–forming cells (ECFCs) from human pluripotent stem cells to treat ischemic cardiovascular diseases BriefCommunication Pages: 1277 - 1277
Synthetic aptamer-polymer hybrid constructs for targeted drug delivery to tumor cells BriefCommunication Pages: 1279 - 1279
Melanin-based nanoparticles for multimodal imaging of melanoma tumors BriefCommunication Pages: 1280 - 1280
